A Preliminary Cost Analysis of Schizophrenic Patients Stabilized on 1-Monthly Long Acting Paliperidone Palmitate (PP1M) Injection Switching To Paliperidone Palmitate 3-Monthly Formulation (PP3M) In The Public Sector of Hong Kong
Abstract
Authors
WY Choon DB Wu KK Lee